2-Phenylacetamide

2-Phenylacetamide (CAS No.: 103-81-1) is an endogenous phenylacetamide metabolite detected in mammalian systems and also isolated from plant sources such as Lepidium apetalum seeds, positioning it at the intersection of metabolic biology and natural product research. This small molecule has attracted attention in neurobiology and metabolic studies due to its involvement in diverse metabolic pathways and its potential to modulate neurotransmitter balance and intracellular signaling networks. Mechanistically, it has been reported to influence the p38 MAPK signaling pathway, which is associated with inflammatory responses, oxidative stress regulation, and fibrotic processes, thereby contributing to observed anti-inflammatory, antioxidant, anti-hypertensive, and anti-fibrotic activities in preclinical models. Although detailed quantitative potency data are limited, its biological effects are generally characterized in the micromolar concentration range in vitro, with functional outcomes dependent on cellular context and assay design. In experimental settings, 2-Phenylacetamide is widely employed as a probe to investigate metabolic network regulation, biomarker discovery, and neurotransmission-related pathways in both cell-based assays and animal models, supporting research into the pathophysiology of metabolic and neurodegenerative disorders as well as the identification of novel therapeutic targets.